A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
NCT ID: NCT03209570
Last Updated: 2019-07-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2017-10-19
2018-08-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Data Collection for Development of a Bladder Sensor During Urodynamics
NCT05305846
TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence
NCT00463554
The Integration of Sensor Technology in Disposable Pads: a Needs Assessment in Nursing Homes
NCT04752306
The Efficacy and Safety of Fotona Smooth® Device for the Treatment of Stress Urinary Incontinence
NCT03098992
Urinary Incontinence Self-Screen for Healthy Aging
NCT03485872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are several drawbacks to current programs. Manually recorded wet checks do not identify when incontinence occurs, only when wetness is detected, reducing the precision of time of incontinence to the window of time between checks. Nursing home staff create individualized care plans for each resident, based on standard check and change procedures, but poor precision in ascertaining timing and quantity of incontinence episodes can contribute to less frequent resident toileting or changing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENA Identifi with sensor wear data
All individuals in this arm will receive care planning using TENA Identifi sensor wear data
Care planning using TENA Identifi sensor wear data
All individuals in this arm will receive TENA Identifi sensor wear and will have data available for care planning.
TENA Identifi without sensor wear data
All individuals in this arm will receive care planning without using TENA Identifi sensor wear data
Care planning without using TENA Identifi sensor wear data
All individuals in this arm will receive TENA Identifi sensor wear but the sensor wear data will not be used for care planning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Care planning using TENA Identifi sensor wear data
All individuals in this arm will receive TENA Identifi sensor wear and will have data available for care planning.
Care planning without using TENA Identifi sensor wear data
All individuals in this arm will receive TENA Identifi sensor wear but the sensor wear data will not be used for care planning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Long-stay status (more than 90 days)
3. Ambulatory and able to use a toilet either independently or with assistance
4. Minimum Data Set (MDS) Level 1 (occasionally), 2 (frequently) or 3 (always) rating of incontinence
5. Currently wearing disposable briefs for urinary incontinence
Exclusion Criteria
2. MDS self-performance rating of 4 (total dependence) for toilet use
3. Fecal incontinence (MDS H0400 rating 0)
4. Use of urinary appliance such as catheters or ostomies (MDS H0100 Z)
5. Private duty nurse care
6. Residents who tear at clothing or disposable undergarments
7. Current urinary tract infection receiving treatment
8. Current diarrhea receiving treatment
9. Residents who are not likely to benefit from a toileting plan based on assessment of nursing staff
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Essity Hygiene and Health AB
INDUSTRY
Insight Therapeutics, LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Gravenstein, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Brown University
H Edward Davidson, PharmD, MPH
Role: PRINCIPAL_INVESTIGATOR
Insight Therapeutics, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chesapeake Health & Rehabilitation Center
Chesapeake, Virginia, United States
Norfolk Health & Rehabilitation Center
Norfolk, Virginia, United States
Insight Therapeutics, LLC
Norfolk, Virginia, United States
Westminster-Canterbury on Chesapeake Bay
Virginia Beach, Virginia, United States
Beth Sholom Village
Virginia Beach, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, Bates-Jensen B. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA. 1995 May 3;273(17):1366-70.
Omli R, Skotnes LH, Romild U, Bakke A, Mykletun A, Kuhry E. Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age Ageing. 2010 Sep;39(5):549-54. doi: 10.1093/ageing/afq082. Epub 2010 Jul 14.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INSI-201706
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.